WO1994002103A3 - Ovulation inhibitor for hormonal contraception - Google Patents
Ovulation inhibitor for hormonal contraception Download PDFInfo
- Publication number
- WO1994002103A3 WO1994002103A3 PCT/DE1993/000656 DE9300656W WO9402103A3 WO 1994002103 A3 WO1994002103 A3 WO 1994002103A3 DE 9300656 W DE9300656 W DE 9300656W WO 9402103 A3 WO9402103 A3 WO 9402103A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- estrogen
- hormonal
- components
- component
- gestagen
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
- A61K31/567—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in position 17 alpha, e.g. mestranol, norethandrolone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Reproductive Health (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP93915661A EP0651644A1 (en) | 1992-07-24 | 1993-07-26 | Ovulation inhibitor for hormonal contraception |
JP6504082A JPH07509454A (en) | 1992-07-24 | 1993-07-26 | Ovulation suppressants for hormonal contraception |
AU45583/93A AU4558393A (en) | 1992-07-24 | 1993-07-26 | Ovulation inhibitor for hormonal contraception |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DEP4224534.6 | 1992-07-24 | ||
DE4224534A DE4224534A1 (en) | 1992-07-24 | 1992-07-24 | Anti-ovulation agent for hormonal contraception |
Publications (2)
Publication Number | Publication Date |
---|---|
WO1994002103A2 WO1994002103A2 (en) | 1994-02-03 |
WO1994002103A3 true WO1994002103A3 (en) | 1994-05-11 |
Family
ID=6464040
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/DE1993/000656 WO1994002103A2 (en) | 1992-07-24 | 1993-07-26 | Ovulation inhibitor for hormonal contraception |
Country Status (6)
Country | Link |
---|---|
EP (1) | EP0651644A1 (en) |
JP (1) | JPH07509454A (en) |
AU (1) | AU4558393A (en) |
CA (1) | CA2140011A1 (en) |
DE (1) | DE4224534A1 (en) |
WO (1) | WO1994002103A2 (en) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4429374C1 (en) * | 1994-08-12 | 1996-02-01 | Jenapharm Gmbh | Pharmaceutical preparations for contraception / hormone substitution with biogenic estrogen component |
DE19504227C2 (en) * | 1995-02-09 | 1999-04-29 | Klaus Dr Med Umbreit | Anti-ovulation agent for hormonal contraception |
DE19525017A1 (en) * | 1995-06-28 | 1997-01-02 | Schering Ag | Pharmaceutical combination preparation, kit and method for hormonal contraception |
DE19540253C2 (en) * | 1995-10-28 | 1998-06-04 | Jenapharm Gmbh | Multi-phase preparation for contraception based on natural estrogens |
WO1998004267A1 (en) * | 1996-07-26 | 1998-02-05 | American Home Products Corporation | Progestin/estrogen oral contraceptive |
TR200002243T2 (en) | 1997-11-10 | 2000-12-21 | Memorial Sloan-Kettering Cancer Center | Process for the preparation of arsenic trioxide and their use for cancer treatment. |
DE10100911A1 (en) | 2001-01-11 | 2002-08-01 | Schering Ag | Process for hormone replacement therapy and its dosage form |
DK1293210T3 (en) * | 2001-05-23 | 2004-03-15 | Pantarhei Bioscience Bv | Hormonal Contraceptives and Methods |
EP2305229A1 (en) | 2001-12-05 | 2011-04-06 | Teva Women's Health, Inc. | Oral contraceptives to prevent pregnancy and diminish premenstrual symptomatology |
EP1648382A4 (en) * | 2003-07-16 | 2009-09-16 | Duramed Pharmaceuticals Inc | Methods of hormonal treatment utilizing contraceptive regimens with continuous estrogen administration |
DE102004019743B4 (en) | 2004-04-20 | 2008-11-27 | Bayer Schering Pharma Aktiengesellschaft | Multiphase preparation for contraception based on natural estrogen |
DE102004026671A1 (en) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Dosage form for hormonal contraception |
DE102004026670A1 (en) | 2004-05-28 | 2005-12-15 | Grünenthal GmbH | Hormonal contraceptive containing a combination of ethinylestradiol and chlormadinone acetate |
US20070111975A1 (en) | 2004-10-07 | 2007-05-17 | Duramed Pharmaceuticals, Inc. | Methods of Hormonal Treatment Utilizing Ascending-Dose Extended Cycle Regimens |
US8153616B2 (en) | 2005-10-17 | 2012-04-10 | Bayer Pharma Aktiengesellschaft | Combination preparation for oral contraception and oral therapy of dysfunctional uterine bleeding containing estradiol valerate and dienogest and method of using same |
EP1930010A1 (en) | 2006-10-20 | 2008-06-11 | Bayer Schering Pharma Aktiengesellschaft | Application of estradiol valerate or 17ß-estradiol in combination with dienogest for oral therapy to maintain and/or increase the female libido |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499348A1 (en) * | 1991-02-09 | 1992-08-19 | Ehrlich, Marika, Dr. med. | Ovulation-inhibiting agent for hormonal contraception |
-
1992
- 1992-07-24 DE DE4224534A patent/DE4224534A1/en not_active Ceased
-
1993
- 1993-07-26 EP EP93915661A patent/EP0651644A1/en not_active Withdrawn
- 1993-07-26 WO PCT/DE1993/000656 patent/WO1994002103A2/en not_active Application Discontinuation
- 1993-07-26 AU AU45583/93A patent/AU4558393A/en not_active Abandoned
- 1993-07-26 CA CA002140011A patent/CA2140011A1/en not_active Abandoned
- 1993-07-26 JP JP6504082A patent/JPH07509454A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0499348A1 (en) * | 1991-02-09 | 1992-08-19 | Ehrlich, Marika, Dr. med. | Ovulation-inhibiting agent for hormonal contraception |
Also Published As
Publication number | Publication date |
---|---|
WO1994002103A2 (en) | 1994-02-03 |
AU4558393A (en) | 1994-02-14 |
EP0651644A1 (en) | 1995-05-10 |
CA2140011A1 (en) | 1994-01-25 |
JPH07509454A (en) | 1995-10-19 |
DE4224534A1 (en) | 1994-01-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2091069C1 (en) | Agent for hormonal contraception that inhibits ovulation | |
AU703064B2 (en) | Means and method for hormonal contraception and/or acne treatment | |
IL122109A0 (en) | A two-stage pharmaceutical preparation for hormonal contraception and a kit containing the same | |
WO1994002103A3 (en) | Ovulation inhibitor for hormonal contraception | |
UA41401C2 (en) | Pharmaceutical combined contraceptive agent | |
AU5646296A (en) | Pharmaceutical combination preparation for hormonal contraception | |
KR890001564A (en) | Pharmaceutical dosage unit | |
CA2248841A1 (en) | Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy | |
MX9707009A (en) | Once-a-month-injectable useful as depot contraceptive and in hormone replacement therapy for perimenopausal and premenopausal women. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AU BR CA FI HU JP NO RU UA US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 1993915661 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2140011 Country of ref document: CA |
|
ENP | Entry into the national phase |
Ref document number: 1995 374595 Country of ref document: US Date of ref document: 19950414 Kind code of ref document: A |
|
WWP | Wipo information: published in national office |
Ref document number: 1993915661 Country of ref document: EP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 1993915661 Country of ref document: EP |